News

Sales started to slow in the spring, as market uncertainty began to weigh on investor confidence, says CEO James O’Sullivan ...
Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...
Shares Expanded Tech Sector has seen a significant rebound but remains fairly valued with a mixed technical outlook. Learn ...
IGM Financial Inc. reported adjusted net earnings of $237.8 million for the first quarter, up 5.9% from the same quarter of ...
IGM Financial Inc (IGIFF) reports record earnings and significant asset growth, while navigating market volatility and strategic challenges.
IGM Financial Inc. (TSX: IGM) held its Annual Meeting of Shareholders earlier today. All of the nominees for election as directors listed in its management proxy circular dated February 24, 2025 were ...
Thank you for standing by. This is the conference operator. Welcome to the IGM Financial First Quarter 2025 Analyst Call and Webcast. As a reminder, all participants are in a listen-only mode and ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.